A−91/100
Desk Score
Dispatch #2Editorial
Vaylen
The strongest all-rounder among the newer entrants — low pricing, brand access, oral routes, and all 50 states on one account.
Visit Vaylen ↗Editorial — no commercial relationship.
- Semaglutide
- $179/mo
- Tirzepatide
- $239/mo
- Coverage
- All 50 states
- Brand-name
- Yes
Desk Score breakdown
Each of the six scored dimensions. See the methodology.
Price transparency88/100
State access96/100
Molecule range96/100
Onboarding speed86/100
Support responsiveness84/100
Licensing & trust90/100
What the Desk likes
- Brand-name and compounded access on both molecules
- Oral and injectable routes available
- Nationwide 50-state coverage at below-market pricing
Where points come off
- Newer operator with a shorter track record
- Support depth still unproven at scale
The Desk's briefing — A−
Best for: People who want maximum optionality — brand or compounded, oral or injectable — without giving up nationwide reach.
Vaylen ranks #2 of 25 providers scored — see #1, CoreAge Rx on the board.
Related dispatches
- #1CoreAge Rx94/100 · A
- #3Ondra Health90/100 · A−
- #4Invigor Medical90/100 · A−
- #5Vytora Health90/100 · A−
- #6Tyde Wellness89/100 · B+
- #7Effecty89/100 · B+
- #8Curex88/100 · B+
- #9AgelessRx87/100 · B+
- #10BetterMe Rx86/100 · B
- #11Eden85/100 · B
- #12Fitish85/100 · B
- #13RxSpan MD85/100 · B
- #14REMEVi85/100 · B
- #15ShedRx83/100 · B
- #16Ro81/100 · B−
- #17Primary Clinic (Direct GLP)80/100 · B−
- #18Peak Wellness80/100 · B−
- #19Found79/100 · C+
- #20Mochi Health79/100 · C+
- #21Optimized Health78/100 · C+
- #22Fella Health78/100 · C+
- #23Henry Meds77/100 · C+
- #24Hims & Hers76/100 · C
- #25HydraMed76/100 · C
Pricing and verification reflect Vaylen's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on Vaylen's site. Not medical advice; see our disclosure.